Latest Biopharma Innovation:
Autonomous, Scalable & Cost-Effective Solutions For Downstream Processing
The world of bioprocessing is evolving rapidly, demanding solutions that prioritize efficiency, flexibility, and innovation. In this webinar, discover how Shimadzu and Sepragen are reshaping the biopharmaceutical landscape with end-to-end solutions.
Shimadzu's high-performance liquid chromatography (HPLC) for pharmaceutical research and quality control seamlessly complements Sepragen's Chromatography and Buffer Blending Systems, streamlining operations, boosting productivity, and reducing costs—helping biopharma manufacturers overcome today’s challenges and meet tomorrow’s needs.
In this session, discover how Sepragen enables seamless scale-up across their downstream bioprocessing workflow, from their novel Superflo Radial Flow Column and QuantaSep Trusty Series bench-scale chromatography to the smart scale-up of automated chromatography. Learn how to optimize workflows, minimize footprints, ensure consistent product quality, and achieve effortless scalability— while maintaining full compliance throughout development and production.
Be part of the conversation as we dive into real-world case studies and industry best practices, showcasing the transformative impact of these technologies. Register Now!
Learning Objectives:
Explore how Quantasep empowers bioprocess engineers to address the challenges of modern biomanufacturing while achieving substantial cost savings.
Learn about cutting-edge bioprocessing solutions designed to optimize time efficiency and enable smarter upscaling.
Gain insights into maintaining compliance and product quality without compromise in your biomanufacturing processes.
Liw Wan Tung
Manager (Biopharma/LC/Spectro)
Shimadzu (Asia Pacific) Pte Ltd
Ms. Wan Tung is the Manager in charge of pharmaceutical market expansion and LC/Spectro products at Shimadzu Asia Pacific Pte Ltd. She specializes in providing technical consultation to researchers and laboratory professionals, helping them optimize methodologies to achieve accurate and reliable results. With over 15 years of experience in analytical science, Wan Tung is recognized as an expert in LC/SFC/MS technologies. Her expertise spans a broad spectrum of areas, including QAQC regulatory compliance, impurity analysis, drug discovery, and biopharmaceutical applications.
Before joining Shimadzu, she began her career as a QA/QC chemist at a multinational pharmaceutical company. She holds a Bachelor's Honours degree in Chemistry from the University Tunku Abdul Rahman (UTAR).
Vinit Saxena
Founder & CEO
Sepragen Corporation
Mr. Vinit Saxena is the founder and CEO of Sepragen Corporation, which specializes in innovative bio-processing equipment and consumables for producing and purifying biological drugs, nutritional ingredients, and vaccines. Sepragen's patented technologies are utilized globally, contributing to the production of over 40 FDA-approved drugs, including hundreds of millions of doses of two prominent COVID-19 vaccines. The company serves leading biopharma clients across four continents, including Abbvie, Amgen, Novartis, Sanofi, Takeda, Serum Institute and Biocon as well as major nutritional companies like Arla and Mead Johnson.
With over 35 years of industry experience in marketing and manufacturing, Mr. Saxena holds degrees from IIT Kanpur, Syracuse University, and U.C. Berkeley. He has authored over 15 patents and numerous publications, and has been a prominent speaker at industry conferences. Additionally, he serves on the Scientific Advisory Board of The Keck Graduate Institute and has received several SBIR grants and the prestigious IR 100 award.